›‹

1
2
3
4
5
6
7

Event Details

MIMEDX GROUP INC at the 15th Annual Needham Healthcare Conference

Apr 12, 2016 8:00 am EDT

Webcast Presentation

Click here for webcast

Title

MIMEDX GROUP INC at the 15th Annual Needham Healthcare Conference

Date / Time

Apr 12, 2016 8:00 am EDT

News and Events

Mar 28, 2018

Summary Toggle MiMedx Enrolls First Patient In Its Phase 2B Clinical Trial Of RMAT Designated AmnioFix® Injectable For The Treatment Of Osteoarthritis Of The Knee

Initiation of Phase 2B Study Follows Quickly After FDA Grants RMAT Designation for Knee OA MARIETTA, Ga. , March 28, 2018 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), a leading developer and marketer of regenerative and therapeutic biologics, today announced that the first patient has been

Read More
Mar 26, 2018

Summary Toggle MiMedx To Participate In The Needham Healthcare Conference

MARIETTA, Ga. , March 26, 2018 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), a leading developer and marketer of regenerative and therapeutic biologics, announced today that it will participate in the 17th Annual Needham Healthcare Conference in New York on Wednesday, March 28, 2018 .

Read More
Mar 26, 2018

Summary Toggle MiMedx Reports Positive Pain And Foot Function Results From Phase 2B Clinical Trial Of AmnioFix® Injectable In The Treatment Of Plantar Fasciitis

Patients Experienced Clinically Meaningful Reduction in Pain AmnioFix Injectable Achieves Primary and Secondary Efficacy Endpoints Statistically Significant Difference in Pain and Function Compared to Placebo MARIETTA, Ga. , March 26, 2018 /PRNewswire/ -- MiMedx Group, Inc.

Read More

Products

CONTACT US

888.543.1917